Jonathan M Zuidema
Overview
Explore the profile of Jonathan M Zuidema including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saksena J, Hamilton A, Gilbert R, Zuidema J
Front Cell Neurosci
. 2023 Nov;
17:1266019.
PMID: 37941607
Central nervous system (CNS) glia, including astrocytes, microglia, and oligodendrocytes, play prominent roles in traumatic injury and degenerative disorders. Due to their importance, active pharmaceutical ingredients (APIs) are being developed...
2.
Vijayakumar S, Nasr S, Davis J, Wang E, Zuidema J, Lu Y, et al.
Nanoscale
. 2022 Nov;
14(47):17700-17713.
PMID: 36416809
Evaluation of Gastrointestinal Stromal Tumors (GIST) during initial clinical staging, surgical intervention, and postoperative management can be challenging. Current imaging modalities (, PET and CT scans) lack sensitivity and specificity....
3.
Kumeria T, Wang J, Kim B, Park J, Zuidema J, Klempner M, et al.
ACS Biomater Sci Eng
. 2022 Oct;
8(10):4140-4152.
PMID: 36210772
Porous silicon (pSi) nanoparticles are loaded with Immunoglobulin A-2 (IgA2) antibodies, and the assembly is coated with pH-responsive polymers on the basis of the Eudragit family of enteric polymers (L100,...
4.
Waggoner L, Kang J, Zuidema J, Vijayakumar S, Hurtado A, Sailor M, et al.
Bioconjug Chem
. 2022 Aug;
33(9):1685-1697.
PMID: 36017941
Traumatic brain injury (TBI) is a major cause of disability and death among children and young adults in the United States, yet there are currently no treatments that improve the...
5.
Neri M, Kang J, Zuidema J, Gasparello J, Finotti A, Gambari R, et al.
ACS Biomater Sci Eng
. 2021 Sep;
8(10):4123-4131.
PMID: 34468123
Peptide nucleic acids (PNAs) are a class of artificial oligonucleotide mimics that have garnered much attention as precision biotherapeutics for their efficient hybridization properties and their exceptional biological and chemical...
6.
Gottipati M, Zuidema J, Gilbert R
Curr Opin Biomed Eng
. 2021 Jul;
14:67-74.
PMID: 34296048
Astrocytes are dynamic cells residing in the central nervous system exhibiting many diverse functions. Astrocytes quickly change and present unique phenotypes in response to injury or disease. Here, we briefly...
7.
Zuidema J, Dumont C, Wang J, Batchelor W, Lu Y, Kang J, et al.
Adv Funct Mater
. 2020 Sep;
30(25).
PMID: 32982626
Scaffolds made from biocompatible polymers provide physical cues to direct the extension of neurites and to encourage repair of damaged nerves. The inclusion of neurotrophic payloads in these scaffolds can...
8.
Zuidema J, Bertucci A, Kang J, Sailor M, Ricci F
Nanoscale
. 2020 Jan;
12(4):2333-2339.
PMID: 31930266
Synthetic DNA-based oligonucleotides are loaded into porous silicon nanoparticles (pSiNPs) and incorporated into nanofibers of poly(lactide-co-glycolide) (PLGA), poly-l-lactic acid (PLA), or polycaprolactone (PCL). The resulting hybrid nanofibers are characterized for...
9.
Kang J, Kim D, Wang J, Han Y, Zuidema J, Hariri A, et al.
Adv Mater
. 2019 Oct;
31(41):e1905454.
PMID: 31595594
No abstract available.
10.
Bertucci A, Kim K, Kang J, Zuidema J, Lee S, Kwon E, et al.
ACS Appl Mater Interfaces
. 2019 Jun;
11(27):23926-23937.
PMID: 31251556
Silencing of aberrantly expressed microRNAs (miRNAs or miRs) has emerged as one of the strategies for molecular targeted cancer therapeutics. In particular, miR-21 is an oncogenic miRNA overexpressed in many...